Kassab, Muzaffer Ahmad
Chen, Yibin
Wang, Xin
He, Bo
Brown, Eric J.
Yu, Xiaochun
Funding for this research was provided by:
National Cancer Center (CA132755, CA130899, CA187209)
Article History
Received: 7 February 2023
Accepted: 26 June 2024
First Online: 8 July 2024
Declarations
:
: The 10–20-week-old C57BL/6 mice used in this study were maintained in the pathogen-free animal facilities at City of Hope (Duarte, CA). The experimental protocols (Protocol #15029) were approved by the City of Hope Institutional Animal Care and Use Committee.
: Not applicable.
: E.J.B. serves on the scientific advisory board of Aprea Therapeutics, and he consults for and holds equity in this company. MAK, YC, XW, BH, and XY declare that they have no competing interests.